HDST - Headstrong Group, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.0000
0.0000 (0.00%)
At close: 12:26PM EDT
Stock chart is not supported by your current browser
Previous Close0.0000
Open0.0000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.0000 - 0.0000
52 Week Range0.0000 - 460.0000
Volume18,000
Avg. Volume0
Market Cap14
Beta (3Y Monthly)-122.02
PE Ratio (TTM)N/A
EPS (TTM)-0.7090
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • ACCESSWIRE

    SHAREHOLDER ALERT - Helius Medical Technologies, Inc. (HSDT) - Bronstein, Gewirtz & Grossman, LLC Alerts Investors of Class Action and Lead Deadline: September 9, 2019

    NEW YORK, NY / ACCESSWIRE / July 19, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Helius Medical Technologies, Inc.(“Helius” or the “Company”) (NASDAQ: HSDT) and certainof its officers, on behalf of shareholders who purchased or otherwise acquired Helius securities from November 9, 2017 and April 10, 2019, inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. On January 25, 2019, Helius said that it had received a request for additional data and information from the U.S. Food and Drug Administration (the “FDA”) related to the its request for de novo classification and 510(k) clearance of its Portable Neuromodulation Stimulator (PoNS™) device.

  • ACCESSWIRE

    SHAREHOLDER ALERT - Helius Medical Technologies, Inc. (HSDT) - Bronstein, Gewirtz & Grossman, LLC Alerts Shareholders of Class Action and Lead Deadline: September 9, 2019

    NEW YORK, NY / ACCESSWIRE / July 17, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Helius Medical Technologies, Inc.(“Helius” or the “Company”) (NASDAQ: HSDT) and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Helius securities from November 9, 2017 and April 10, 2019,inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. On January 25, 2019, Helius said that it had received a request for additional data and information from the U.S. Food and Drug Administration (the “FDA”) related to the its request for de novo classification and 510(k) clearance of its Portable Neuromodulation Stimulator (PoNS™) device.

  • ACCESSWIRE

    SHAREHOLDER ALERT - Helius Medical Technologies, Inc. (HSDT) - Bronstein, Gewirtz & Grossman, LLC Announces Class Action and Lead Deadline: September 9, 2019

    NEW YORK, NY / ACCESSWIRE / July 12, 2019 / Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Helius Medical Technologies, Inc.(“Helius” or the “Company”) (NASDAQ: HSDT) and certainof its officers, on behalf of shareholders who purchased or otherwise acquired Helius securities from November 9, 2017 and April 10, 2019,inclusive (the “Class Period”). This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934. On January 25, 2019, Helius said that it had received a request for additional data and information from the U.S. Food and Drug Administration (the “FDA”) related to the its request for de novo classification and 510(k) clearance of its Portable Neuromodulation Stimulator (PoNS™) device.